Predictive Oncology Inc. — Director's Dealing 2018

Nov 23, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Precision Therapeutics Inc. (AIPT)
CIK: 0001446159
Period of Report: 2018-11-20

Reporting Person: GABRIEL RICHARD L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-20	Common Stock	P	1000	$0.89	Acquired	1000	Direct